Winston & Strawn Briefing

CHARLOTTE
CHICAGO
GENEVA
HONG KONG
LONDON
LOS ANGELES
MOSCOW
NEW YORK
NEWARK
PARIS
SAN FRANCISCO
WASHINGTON, D.C.

www.winston.com

 

October 2009

SPECIAL ALERT

FTC Enters Into Final Consent Agreement Regarding Product Claims

The FTC entered a final consent agreement with Constellation Brands concerning the FTC’s charges that ads for Wide Eye caffeinated schnapps were deceptive.   Wide Eye was a schnapps product containing 30 percent alcohol by volume.  Ad claims included “Wake Up @WideEye.com,” “I am your wake up call,” and “When you party with the world’s first caffeinated schnapps it’ll seem like the rest of the world is sleepwalking through life.”  According to the FTC, these claims expressly or by implication promised that consumers will remain alert while consuming Wide Eye.  A number of state attorneys general had also called on the FTC to crack down on Wide Eye, arguing that it, like other popular energy drinks, appealed to youth and underage drinkers.  Prior to product launch, Constellation had obtained all required U.S. Alcohol & Tobacco Tax & Trade Bureau (TTB) approvals for Wide Eye and the product’s brand name and tagline were subsequently found to be in accordance with the voluntary DISCUS Code of Responsible Marketing Practices.

The consent agreement, which does not constitute an admission of a violation of law, prohibits Constellation from representing “expressly or by implication, including through the use of a product name or endorsement, that such product…will counteract the effects of alcohol consumption” unless the advertiser has “competent and reliable scientific evidence” supporting that representation.  The FTC order pertains not just to Wide Eye, but also to any other alcohol product containing caffeine, ginseng, taurine, guarana, or any stimulant.  The Order puts any such Constellation products under the FTC’s close eye until the order expires in 2029. 

Practice Tip:  All claims for a product, including a name that might imply a claim, must be supported by competent and scientific evidence in the advertiser’s possession at the time the claim is made. 

 

 

If you have any questions concerning this Advertising & Promotion Law News Special Alert, please contact one of the following attorneys:
           
Chicago   Los Angeles   Paris  
Monique N. Bhargava 312-558-3732 David L. Aronoff 213-615-1866 Nathalie Hadjadj-Cazier 33 (0) 1 53 64 81 50
Stephen P. Durchslag 312-558-5288 Steven D. Atlee 213-615-1827    
Brian D. Fergemann 312-558-8024     San Francisco  
Jason W. Gordon 312-558-6145 New York   David S. Bloch 415-591-1452
Brian L. Heidelberger 312-558-5897 Michael S. Elkin 212-294-6745 Andrew P. Bridges 415-591-1482
Robert H. Newman 312-558-8125 Thomas P. Lane 212-294-6869 Kimberly A. Eckhart 415-591-6805
Mary Hutchings Reed 312-558-5721 Michael J. Friedman 212-294-2608 Jennifer A. Golinveaux 415-591-1506
Ronald Y. Rothstein 312-558-7464 Joe DiBenedetto 212-294-6709    
Liisa M. Thomas 312-558-6149 H. Joseph Mello 212-294-6736 Washington, D.C.  
Marc H. Trachtenberg 312-558-7964 Virginia R. Richard 212-294-4639 Michael L. Sibarium 202-282-5702
 


These materials have been prepared by Winston & Strawn for informational purposes only. These materials do not constitute legal advice and cannot be relied upon by any taxpayer for the purpose of avoiding penalties imposed under the Internal Revenue Code. Receipt of this information does not create an attorney-client relationship. No reproduction or redistribution without written permission of Winston & Strawn LLP.

Along with this briefing, a library of all the Winston & Strawn LLP briefings published to date can be accessed by visiting the Publications Library section of Winston & Strawn LLP's Web site (www.winston.com).

Copyright © 2009. Winston & Strawn LLP.